Patents by Inventor Yusuke Imazaki

Yusuke Imazaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tertiary amide derivatives substituted with 4-membered ring structure
    Patent number: 12673941
    Abstract: [Problem] The present disclosure provides tertiary amide derivatives substituted with a 4-membered ring structure that are useful as medicines and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and therapeutic agents and/or prophylactic agents for conditions in which CBP/P300 is involved, comprising the composition.
    Type: Grant
    Filed: April 11, 2025
    Date of Patent: July 7, 2026
    Assignees: Sumitomo Pharma Co., Ltd., NATIONAL CANCER CENTER
    Inventors: Shunichiro Uesugi, Yusuke Kamei, Hitoshi Ban, Seiji Kamioka, Yusuke Imazaki, Hideaki Ogiwara, Mariko Sasaki
  • Water soluble adjuvant and composition containing same
    Patent number: 12427192
    Abstract: The present invention relates to a compound useful as a vaccine adjuvant for cancer vaccine, a preparation process thereof, a pharmaceutical composition comprising the compound, and use of the compound as a vaccine adjuvant for cancer vaccine.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: September 30, 2025
    Assignee: Sumitomo Pharma Co., Ltd.
    Inventors: Hitoshi Ban, Yosuke Takanashi, Masashi Goto, Natsuko Suginobe, Yusuke Imazaki, Yoshiko Iwata
  • TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE
    Publication number: 20250263415
    Abstract: [Problem] The present disclosure provides tertiary amide derivatives substituted with a 4-membered ring structure that are useful as medicines and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and therapeutic agents and/or prophylactic agents for conditions in which CBP/P300 is involved, comprising the composition.
    Type: Application
    Filed: February 6, 2025
    Publication date: August 21, 2025
    Applicants: Sumitomo Pharma Co., Ltd., NATIONAL CANCER CENTER
    Inventors: Shunichiro UESUGI, Yusuke KAMEI, Hitoshi BAN, Seiji KAMIOKA, Yusuke IMAZAKI, Hideaki OGIWARA, Mariko SASAKI
  • TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE
    Publication number: 20250257055
    Abstract: [Problem] The present disclosure provides tertiary amide derivatives substituted with a 4-membered ring structure that are useful as medicines and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and therapeutic agents and/or prophylactic agents for conditions in which CBP/P300 is involved, comprising the composition.
    Type: Application
    Filed: April 11, 2025
    Publication date: August 14, 2025
    Applicants: Sumitomo Pharma Co., Ltd., NATIONAL CANCER CENTER
    Inventors: Shunichiro UESUGI, Yusuke KAMEI, Hitoshi BAN, Seiji KAMIOKA, Yusuke IMAZAKI, Hideaki OGIWARA, Mariko SASAKI
  • ADJUVANT WITH TLR4 AGONIST ACTIVITY
    Publication number: 20230287027
    Abstract: The present invention relates to a compound useful as vaccine adjuvant, a manufacturing process thereof, a pharmaceutical composition comprising the compound, and use of the compound as vaccine adjuvant.
    Type: Application
    Filed: June 21, 2021
    Publication date: September 14, 2023
    Applicant: Sumitomo Pharma Co., Ltd.
    Inventors: Hitoshi BAN, Yusuke IMAZAKI, Yosuke TAKANASHI, Akihisa FUKUSHIMA
  • WATER SOLUBLE ADJUVANT AND COMPOSITION CONTAINING SAME
    Publication number: 20220241409
    Abstract: The present invention relates to a compound useful as a vaccine adjuvant for cancer vaccine, a preparation process thereof, a pharmaceutical composition comprising the compound, and use of the compound as a vaccine adjuvant for cancer vaccine.
    Type: Application
    Filed: April 3, 2020
    Publication date: August 4, 2022
    Inventors: Hitoshi Ban, Yosuke Takanashi, Yusuke Imazaki
  • WATER SOLUBLE ADJUVANT AND COMPOSITION CONTAINING SAME
    Publication number: 20220211844
    Abstract: The present invention relates to a compound useful as a vaccine adjuvant for cancer vaccine, a preparation process thereof, a pharmaceutical composition comprising the compound, and use of the compound as a vaccine adjuvant for cancer vaccine.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 7, 2022
    Inventors: Hitoshi Ban, Yosuke Takanashi, Masashi Goto, Natsuko Suginobe, Yusuke Imazaki, Yoshiko Iwata